GERON CORP Public Float
GERON CORP (GERN) had Public Float of $860.50 million as of 2025-06-30, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-02
- 2025-06-30: Entity Public Float $860.50M.
- 2024-06-30: Entity Public Float $2.43B.
- 2023-06-30: Entity Public Float $1.39B.
- 2022-06-30: Entity Public Float $503.19M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $860.50M 10-K · filed 2026-03-02 |
| 2024-06-30 | $2.43B 10-K · filed 2025-02-27 |
| 2023-06-30 | $1.39B 10-K · filed 2024-02-28 |
| 2022-06-30 | $503.19M 10-K · filed 2023-03-16 |
| 2021-06-30 | $376.70M 10-K · filed 2022-03-10 |
| 2020-06-30 | $516.43M 10-K · filed 2021-03-11 |
| 2019-06-28 | $262.46M 10-K · filed 2020-03-12 |
| 2018-06-29 | $623.08M 10-K · filed 2019-03-07 |
| 2017-06-30 | $438.71M 10-K · filed 2018-03-16 |
| 2016-06-30 | $424.38M 10-K · filed 2017-03-01 |
| 2015-06-30 | $673.35M 10-K · filed 2016-03-10 |
| 2014-06-30 | $501.00M 10-K · filed 2015-03-11 |
| 2013-06-30 | $193.22M 10-K · filed 2014-03-17 |
| 2012-06-30 | $219.81M 10-K · filed 2013-03-15 |
| 2011-06-30 | $508.64M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |